Compare ARK Genomic Revolution ETF (ARKG) vs Cigna Corp (CI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Cigna Corp — how do they compare? ARK Genomic Revolution ETF trades at $44.36, while Cigna Corp trades at $273 (market cap $73.56B). The key difference: Cigna Corp pays a 2.24% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Cigna Corp nearer its low. Which is the better fit depends on your goals.
| ARKG | CI | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $44.55 | $311.00 |
52-Week Low | $24.02 | $244.41 |
Market Cap | — | $73.56B |
Enterprise Value | — | $98.27B |
Dividend Yield | — | 2.24% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →
